New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.
about
Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle AtrophyAnimal models of metabolic syndrome: a reviewType 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients.Relationship Between Glucocorticoids and Insulin Resistance in Healthy Individuals.Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications.Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics.Leveraging melanocortin pathways to treat glomerular diseases.The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.Negative Cardiovascular Consequences of Small Molecule Immunosuppressants.The Central Nervous System Regulates Embryonic HSPC Production via Stress-Responsive Glucocorticoid Receptor Signaling.Adipose stem cells from obese patients show specific differences in the metabolic regulators vitamin D and Gas5.Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy.Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts.Polygonum multiflorum Decreases Airway Allergic Symptoms in a Murine Model of Asthma.Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 Mice.Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.Gender differences in non-glycemic responses to improved insulin sensitivity by pioglitazone treatment in patients with type 2 diabetes
P2860
Q28072006-8CFA38DF-86F5-4ED6-9AEB-CCB6BC7B63F2Q28072861-0DD007F0-801C-464C-9726-8C42E29592B1Q33756414-87417F56-DBE4-4395-8CE0-8BFE47918F36Q36102736-21201774-20DE-4E38-80AA-645C3D459162Q37021004-8AD65321-7B8E-403F-BAAD-FEA212A8F7C3Q37193551-807494EF-314E-4EA6-BA15-2A021A781CA1Q37217417-ACFD6118-D7E0-4005-8037-12347F701999Q37632054-253946A7-7E8B-456A-B041-87AABAE3D56FQ38436495-2A3A8CED-3473-453C-B6E1-570161749A31Q38571198-5C88A4C0-D8B5-4FA2-8135-03B0A3983A0AQ38661520-B7292998-9B6C-4E71-AF38-93EF75541683Q39079582-DBE099DC-0C84-491B-AB45-085A74B1103EQ39312540-B7C9D16A-52B8-46AE-A434-C5EBBFDD873AQ39594101-C4D86313-815B-4F2A-801E-7EE14DE726A0Q42205759-B589EF47-30CF-429F-8384-55149C76910BQ43671913-52D8ED12-D820-400A-8AA8-DFDCB22DBEF6Q46590090-9EAF9D70-C986-4025-A67E-D75EFD6BC918Q46704329-D91E691D-ACC1-4FFE-91D4-6A5590061B5BQ48137778-21BA8587-9411-48F7-8893-EB297DB32E72Q49971559-0E163195-B275-44B6-9815-BDF83D9071A5Q51744585-20977779-BA22-4CF0-AF89-023303759BC0Q58329628-2E3B46E4-CF43-4D3C-AA3A-8622276E365C
P2860
New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.
@en
type
label
New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.
@en
prefLabel
New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.
@en
P2860
P356
P1476
New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.
@en
P2860
P304
P356
10.1172/JCI66180
P407
P577
2012-10-24T00:00:00Z